↓ Skip to main content

Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects

Overview of attention for article published in BMC Cancer, April 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
96 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects
Published in
BMC Cancer, April 2018
DOI 10.1186/s12885-018-4380-z
Pubmed ID
Authors

Stefan Munker, Michael Gerken, Petra Fest, Claudia Ott, Elisabeth Schnoy, Stefan Fichtner-Feigl, Philipp Wiggermann, Martin Vogelhuber, Wolfgang Herr, Christian Stroszczynski, Hans Jürgen Schlitt, Matthias Evert, Michael Reng, Monika Klinkhammer-Schalke, Andreas Teufel

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 96 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 19 20%
Student > Master 12 13%
Student > Doctoral Student 9 9%
Researcher 8 8%
Student > Ph. D. Student 8 8%
Other 12 13%
Unknown 28 29%
Readers by discipline Count As %
Medicine and Dentistry 20 21%
Biochemistry, Genetics and Molecular Biology 15 16%
Nursing and Health Professions 9 9%
Pharmacology, Toxicology and Pharmaceutical Science 9 9%
Agricultural and Biological Sciences 5 5%
Other 5 5%
Unknown 33 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 January 2024.
All research outputs
#3,307,005
of 25,243,120 outputs
Outputs from BMC Cancer
#735
of 8,907 outputs
Outputs of similar age
#63,672
of 332,895 outputs
Outputs of similar age from BMC Cancer
#27
of 224 outputs
Altmetric has tracked 25,243,120 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,907 research outputs from this source. They receive a mean Attention Score of 4.6. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 332,895 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 224 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.